Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Financial Flexibility Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥553.14 Million (operating CF CN¥486.04 Million minus capex CN¥67.11 Million) represents 0% of total liabilities (CN¥3.63 Billion). Also explore Shanghai Shyndec Pharmaceutical Co Ltd (600420) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. Check strategic asset allocation of Shanghai Shyndec Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Year-by-year free cash flow to debt coverage for Shanghai Shyndec Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600420 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥2.48 Billion | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +28.9% |
| 2023 | 0.41x | CN¥2.08 Billion | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -2.0% |
| 2022 | 0.42x | CN¥3.16 Billion | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +67.2% |
| 2021 | 0.25x | CN¥2.20 Billion | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +10.1% |
| 2020 | 0.23x | CN¥1.94 Billion | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +15.8% |
| 2019 | 0.20x | CN¥1.67 Billion | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -23.1% |
| 2018 | 0.26x | CN¥2.07 Billion | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -21.9% |
| 2017 | 0.33x | CN¥2.48 Billion | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +146.9% |
| 2016 | 0.13x | CN¥1.08 Billion | CN¥838.58 Million | CN¥8.08 Billion | ▼ -26.8% |
| 2015 | 0.18x | CN¥461.17 Million | CN¥226.65 Million | CN¥2.53 Billion | ▼ -36.0% |
| 2014 | 0.29x | CN¥689.05 Million | CN¥258.51 Million | CN¥2.42 Billion | ▼ -27.9% |
| 2013 | 0.40x | CN¥720.12 Million | CN¥207.50 Million | CN¥1.82 Billion | ▼ -15.6% |
| 2012 | 0.47x | CN¥598.94 Million | CN¥193.41 Million | CN¥1.28 Billion | ▼ -3.5% |
| 2011 | 0.49x | CN¥264.52 Million | CN¥136.12 Million | CN¥544.70 Million | ▼ -46.6% |
| 2010 | 0.91x | CN¥271.12 Million | CN¥115.11 Million | CN¥298.05 Million | ▲ +51.4% |
| 2009 | 0.60x | CN¥128.73 Million | CN¥97.43 Million | CN¥214.24 Million | ▲ +37.1% |
| 2008 | 0.44x | CN¥71.60 Million | CN¥58.04 Million | CN¥163.41 Million | ▼ -55.1% |
| 2007 | 0.98x | CN¥116.76 Million | CN¥82.31 Million | CN¥119.57 Million | ▼ -38.0% |
| 2006 | 1.57x | CN¥135.59 Million | CN¥73.60 Million | CN¥86.15 Million | ▲ +29.6% |
| 2005 | 1.21x | CN¥129.55 Million | CN¥57.90 Million | CN¥106.67 Million | ▲ +175.1% |
| 2004 | 0.44x | CN¥32.81 Million | CN¥17.02 Million | CN¥74.32 Million | — |